INS and Hypoglycemia: Hypoglycemia is the most common adverse event associated with insulin therapy in these individuals and one of the major limiting factors for the achievement of glycemic goals, since the intensification of insulin therapy for attainment of lower HbA1c levels leads to an increased number of hypoglycemic events (2).